#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Polyneuropathy Extra-osseous Ewing's sarcoma metastatic Prostate cancer Stiff person syndrome X-linked lymphoproliferative syndrome Focal segmental glomerulosclerosis Ewing's sarcoma recurrent Leiomyosarcoma recurrent Phaeochromocytoma Primitive neuroectodermal tumour Chronic graft versus host disease in liver Diffuse large B-cell lymphoma recurrent Isodicentric chromosome 15 syndrome Penile cancer More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Basic Information Hereditary angioedema – Treatment Lennox-Gastaut syndrome – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Sarcoidosis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Acute respiratory distress syndrome – Basic Information Glycogen storage disease type V – Diagnostics Idiopathic inflammatory myopathy – Trials in Disease Idiopathic inflammatory myopathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Envudeucitinib ZINC AZD6234 Dapirolizumab Pegol Tebipenem Pivoxil Hydrobromide ISPAGHULA HUSK Ipn01194 PIPOTIAZINE Ulotaront Axicabtagene Ciloleucel Eye103 Eplontersen RIVASTIGMINE Landiolol Hydrochloride Anhydrous Benzoyl Peroxide Cyclophosphamide Monohydrate AGANIRSEN Transpocart19 GT-002 Sodium 2-Hydroxylinoleate More therapies…

    Learn about Your Condition

    Keratosis follicular Thermal burn Plasma cell myeloma refractory Cervical dysplasia Cardiac sarcoidosis Mesothelioma Hyperphagia Corneal dystrophy Short stature Colorectal cancer Colon cancer stage III Bacteraemia Peritoneal sarcoma Perinatal depression Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ospedale dell’Angelo di Mestre

Ospedale dell’Angelo di Mestre

Via Paccagnella 11, Mestre – Venezia, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Aciclovir
    • Allopurinol
    • Amphotericin B
    Italy

  • Study on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cytarabine
    • Methotrexate
    • Methylprednisolone
    Italy

  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Calcium Levofolinate
    • Cyclophosphamide
    Italy

  • Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Italy
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!